4-(2-Phenylquinazolin-4-yl)morpholine
CAS: 307544-21-4
Ref. 3D-HMA54421
| 1g | To inquire | ||
| 5g | To inquire | ||
| 10g | To inquire | ||
| 250mg | To inquire | ||
| 500mg | To inquire |
Product Information
4-(2-Phenylquinazolin-4-yl)morpholine (4PTQM) is a human liver cancer drug candidate that has potent cytotoxic properties. 4PTQM has been shown to inhibit the phosphoinositide 3-kinase (PI3K) enzyme, which is involved in tumor cell proliferation, migration and survival. It also inhibits the growth of cervical cancer cells in vitro. 4PTQM binds to the pharmacophore of PI3K, which contains a hydrophobic region and several hydrogen bond acceptors. This binding prevents the enzyme from binding its substrate phosphatidylinositol bisphosphate (PIP2), inhibiting its activity. 4PTQM also has been shown to have high cytotoxicity against diploid cells and statistically optimized for potency against cervical cancer cells in vitro.
Chemical properties
Technical inquiry about: 3D-HMA54421 4-(2-Phenylquinazolin-4-yl)morpholine
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
